Author
Listed:
- Wei-Chieh Wang
(National Taiwan University)
- Chu-Hsuan Huang
(Cathay General Hospital
National Tsing Hua University)
- Hsin-Hsiang Chung
(National Taiwan University)
- Pei-Lung Chen
(National Taiwan University
National Taiwan University Hospital)
- Fung-Rong Hu
(National Taiwan University Hospital
National Taiwan University)
- Chang-Hao Yang
(National Taiwan University Hospital
National Taiwan University)
- Chung-May Yang
(National Taiwan University Hospital
National Taiwan University)
- Chao-Wen Lin
(National Taiwan University Hospital)
- Cheng-Chih Hsu
(National Taiwan University
Leeuwenhoek Laboratories Co. Ltd)
- Ta-Ching Chen
(National Taiwan University Hospital
National Taiwan University Hospital
National Taiwan University
National Taiwan University Hospital)
Abstract
The diagnosis of inherited retinal degeneration (IRD) is challenging owing to its phenotypic and genotypic complexity. Clinical information is important before a genetic diagnosis is made. Metabolomics studies the entire picture of bioproducts, which are determined using genetic codes and biological reactions. We demonstrated that the common diagnoses of IRD, including retinitis pigmentosa (RP), cone-rod dystrophy (CRD), Stargardt disease (STGD), and Bietti’s crystalline dystrophy (BCD), could be differentiated based on their metabolite heatmaps. Hundreds of metabolites were identified in the volcano plot compared with that of the control group in every IRD except BCD, considered as potential diagnosing markers. The phenotypes of CRD and STGD overlapped but could be differentiated by their metabolomic features with the assistance of a machine learning model with 100% accuracy. Moreover, EYS-, USH2A-associated, and other RP, sharing considerable similar characteristics in clinical findings, could also be diagnosed using the machine learning model with 85.7% accuracy. Further study would be needed to validate the results in an external dataset. By incorporating mass spectrometry and machine learning, a metabolomics-based diagnostic workflow for the clinical and molecular diagnoses of IRD was proposed in our study.
Suggested Citation
Wei-Chieh Wang & Chu-Hsuan Huang & Hsin-Hsiang Chung & Pei-Lung Chen & Fung-Rong Hu & Chang-Hao Yang & Chung-May Yang & Chao-Wen Lin & Cheng-Chih Hsu & Ta-Ching Chen, 2024.
"Metabolomics facilitates differential diagnosis in common inherited retinal degenerations by exploring their profiles of serum metabolites,"
Nature Communications, Nature, vol. 15(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47911-3
DOI: 10.1038/s41467-024-47911-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-47911-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.